Michael J. Orwat,Donald J. P. Pinto,Leon M. Smith, II,Shefali Srivastava
申请号:
US15918195
公开号:
US10208021B2
申请日:
2018.03.12
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present invention provides compounds of Formula (I):or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.